The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy
Abstract
BACKGROUND: There is little systematic information regarding the immune reconstitution inflammatory syndrome (IRIS). OBJECTIVE: To determine the incidence, risk factors, and long-term outcome of IRIS in HIV-infected patients receiving highly active antiretroviral therapy (HAART) who were coinfected with one of three common opportunistic pathogens. DESIGN: A retrospective cohort identified through a city-wide prospective surveillance program. METHODS: A retrospective chart review was performed for 180 HIV-infected patients who received HAART and were coinfected with Mycobacterium tuberculosis, Mycobacterium avium complex, or Cryptococcus neoformans between 1997 and 2000. Medical records were reviewed for baseline demographics, receipt and type of HAART, response to antiretroviral therapy, development of IRIS, and long-term outcome. RESULTS: In this cohort, 31.7% of patients who received HAART developed IRIS. Patients with IRIS were more likely to have initiated HAART nearer to the time of diagnosis of their opportunistic infection (P < 0.001), to have been antiretroviral naive at time of diagnosis of their opportunistic infection (P < 0.001), and to have a more rapid initial fall in HIV-1 RNA level in response to HAART (P < 0.001). CONCLUSIONS: IRIS is common among HIV-infected persons coinfected with M. tuberculosis, M. avium complex, or C. neoformans. Antiretroviral drug-naive patients who start HAART in close proximity to the diagnosis of an opportunistic infection and have a rapid decline in HIV-1 RNA level should be monitored for development of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A., & Lundgren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
Infections with Cryptococcus neoformans in the Acquired Immunodeficiency Syndrome
Chuck, S. L., & Sande, M. A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909213211205 · Cited by 797
SHELBURNE, S. A., HAMILL, R. J., RODRIGUEZ-BARRADAS, M. C., GREENBERG, S. B., ATMAR, R. L., MUSHER, D. M., GATHE, J. C., VISNEGARWALA, F., & TRAUTNER, B. W. (2002) · Medicine · doi:10.1097/00005792-200205000-00005 · Cited by 654
Self-citationImmune restoration disease after antiretroviral therapy
French, M. A., Price, P., & Stone, S. F. (2004) · AIDS · doi:10.1097/01.aids.0000131375.21070.06 · Cited by 651
Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608
French, M. A., Lenzo, N., John, M., Mallal, S. A., McKinnon, E. J., James, I. R., Price, P., Flexman, J. P., & Tay‐Kearney, M. (2000) · HIV Medicine · doi:10.1046/j.1468-1293.2000.00012.x · Cited by 413
DeSimone, J. A., Pomerantz, R. J., & Babinchak, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00013 · Cited by 383
Race, E. M., Adelson-Mitty, J., Kriegel, G. R., Barlam, T. F., Reimann, K. A., Letvin, N. L., & Japour, A. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04352-3 · Cited by 358
Bucy, R. P., Hockett, R. D., Derdeyn, C. A., Saag, M. S., Squires, K., Sillers, M., Mitsuyasu, R. T., & Kilby, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5863 · Cited by 329
Immune Reconstitution in HIV‐Infected Patients
Hirsch, H. H., Kaufmann, G., Sendi, P., & Battegay, M. (2004) · Clinical Infectious Diseases · doi:10.1086/383034 · Cited by 327
Immunorestitution Disease Involving the Innate and Adaptive Response
Cheng, V. C. C., Yuen, K.-Y., Chan, W.-M., Ma, E. S. K., & Chan, R. M. T. (2000) · Clinical Infectious Diseases · doi:10.1086/313809 · Cited by 214
Immune reconstitution inflammatory syndrome
BRETON, G. (2009) · Tuberculosis · doi:10.1016/b978-1-4160-3988-4.00067-6 · Cited by 206
Karavellas, M. P., Plummer, D. J., Macdonald, J. C., Torriani, F. J., Shufelt, C. L., Azen, S. P., & Freeman, W. R. (1999) · The Journal of Infectious Diseases · doi:10.1086/314639 · Cited by 205
Carr, A., & Cooper, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62892-9 · Cited by 169
Paradoxical Worsening of Tuberculosis in HIV-Infected Persons
Wendel, K. A., Alwood, K. S., Gachuhi, R., Chaisson, R. E., Bishai, W. R., & Sterling, T. R. (2001) · Chest · doi:10.1378/chest.120.1.193 · Cited by 157 · cited 1×
“To date, the information regarding the incidence of IRIS is derived from small samples with widely varying estimates [16,17].”
BackgroundNavas, E., Martín‐Dávila, P., Moreno, L., Pintado, V., Casado, J. L., Fortún, J., Pérez-Elías, M. J., Gomez-Mampaso, E., & Moreno, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.1.97 · Cited by 151
Woods, M. L., MacGinley, R., Eisen, D. P., & Allworth, A. M. (1998) · AIDS · doi:10.1097/00002030-199812000-00011 · Cited by 150
Chariyalertsak, S., Sirisanthana, T., Saengwonloey, O., & Nelson, K. E. (2001) · Clinical Infectious Diseases · doi:10.1086/319348 · Cited by 149
Palella, F. J., Chmiel, J. S., Moorman, A. C., & Holmberg, S. D. (2002) · AIDS · doi:10.1097/00002030-200208160-00007 · Cited by 144
Price, P., Mathiot, N. D., Krueger, R. G., Stone, S. F., Keane, N. M., & French, M. A. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(01)00200-1 · Cited by 118
Brandt, M. E., Hutwagner, L., Klug, L. A., Baughman, W. S., Rimland, D., Graviss, E. A., Hamill, R. J., Thomas, C., Pappas, P. G., Reingold, A. L., et al. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.912-917.1996 · Cited by 111
Self-citationde Jong, M. D., Vella, S., Carr, A. D., Boucher, C. A., Imrie, A. A., French, M. A., Hoy, J., Sorice, S., Pauluzzi, S., Chiodo, F., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514002 · Cited by 67
Paradoxical tuberculous reactions in HIV-infected patients.
Orlovic, D., & Ra, S. (2001) · PubMed · Cited by 60
Sahly, H. M. E., Adams, G. J., Soini, H., Teeter, L. D., & Musser, J. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/318079 · Cited by 59
Exacerbation of the inflammatory response toMycobacterium tuberculosisafter antiretroviral therapy
John, M., & French, M. A. (1998) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb123372.x · Cited by 59
Cinti, S. K., Armstrong, W. S., & Kauffman, C. A. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00663.x · Cited by 38
Cited by
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationTan, C. S., & Koralnik, I. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70040-5 · Cited by 776
Müller, M., Wandel, S., Colebunders, R., Attia, S., Furrer, H., & Egger, M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70026-8 · Cited by 755
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745
Maziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
Metadata
- Authors
- Shelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J.
- Venue
- AIDS
- Published
- 2005-03-04
- Volume
- 19
- Issue
- 4
- Pages
- 399-406
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2125247264
- Cited by
- 632
- References
- 27
- FWCI
- 48.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.